Class information for:
Level 2: STATINS//EZETIMIBE//SIMVASTATIN

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
419 16502 38.2 79%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
171 3       MONASCUS//CITRININ//MONASCUS PURPUREUS 58457
419 2             STATINS//EZETIMIBE//SIMVASTATIN 16502
413 1                   STATINS//LOW DENSITY LIPOPROTEIN CHOLESTEROL//ATORVASTATIN 3505
2292 1                   STATINS//ATORVASTATIN//HMG COA REDUCTASE INHIBITORS 2292
7494 1                   STATINS//RHABDOMYOLYSIS//STATIN INTOLERANCE 1362
8340 1                   STATINS//LOVASTATIN//SIMVASTATIN 1264
9257 1                   PRAVASTATIN//HMG COA REDUCTASE INHIBITORS//MEVALONIC ACID 1173
9366 1                   PCSK9//PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9//ALIROCUMAB 1162
10374 1                   FENOFIBRATE//FENOFIBRIC ACID//FIBRATES 1069
12751 1                   NIACIN//LAROPIPRANT//GPR109A 883
13608 1                   EZETIMIBE//NPC1L1//CHOLESTEROL ABSORPTION INHIBITOR 825
14156 1                   STATINS//SIMVASTATIN//P DIS TB INTERNAL MED 788
15692 1                   STATINS//GRP COGNIT DECLINE DEGENERAT VASC DISORDERS//GRP PHARMACOL CEREBRAL I EMIA 697
18626 1                   PITAVASTATIN//NK 104//CAS 147526 32 7 543
18946 1                   ATORVASTATIN CALCIUM//EZETIMIBE//ROSUVASTATIN CALCIUM 529
23438 1                   BILE ACID SEQUESTRANT//COLESEVELAM HCL//COLESEVELAM 346
37173 1                   BLOOD ELEMENTAL LEVELS//CHOLESTEROL RATIOS//LIPOPROTEIN CHOLESTEROL RATIO 64

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 STATINS authKW 2447902 19% 43% 3116
2 EZETIMIBE authKW 670368 3% 68% 532
3 SIMVASTATIN authKW 605053 5% 40% 828
4 HMG COA REDUCTASE INHIBITORS authKW 549595 3% 54% 555
5 ATORVASTATIN authKW 513346 4% 39% 709
6 PCSK9 authKW 355858 2% 76% 254
7 PRAVASTATIN authKW 292862 2% 46% 347
8 HYPERCHOLESTEROLEMIA authKW 215972 4% 18% 657
9 ROSUVASTATIN authKW 215204 2% 41% 282
10 NIACIN authKW 199106 2% 39% 276

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Cardiac & Cardiovascular System 67961 26% 1% 4262
2 Peripheral Vascular Diseases 26077 12% 1% 2019
3 Pharmacology & Pharmacy 18781 21% 0% 3547
4 Medicine, General & Internal 16053 16% 0% 2582
5 Endocrinology & Metabolism 2273 6% 0% 951
6 Medicine, Research & Experimental 1556 5% 0% 794
7 Primary Health Care 494 1% 0% 106
8 Health Care Sciences & Services 476 2% 0% 262
9 Hematology 279 2% 0% 349
10 Health Policy & Services 279 1% 0% 155

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 INTERNAL MED CLIN PHARMACOL 32307 0% 31% 56
2 CARDIOL 31076 10% 1% 1681
3 OFF HLTH PROMOT DIS PREVENT 25329 0% 57% 24
4 LIPID CLIN 21530 0% 15% 80
5 POINT MED 21511 0% 61% 19
6 BIOCHEM NEUROENDOCRINOL 20806 0% 21% 54
7 CARDIOVASC DIS PREVENT 19527 0% 15% 69
8 VASC MED ATHEROSCLEROSIS UNIT 17636 0% 34% 28
9 HEART DIS PREVENT CLIN 16458 0% 64% 14
10 VASC DIS PREVENT CLIN 15095 0% 22% 37

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 JOURNAL OF CLINICAL LIPIDOLOGY 64609 1% 23% 151
2 ATHEROSCLEROSIS 46420 3% 5% 520
3 AMERICAN JOURNAL OF CARDIOLOGY 40171 5% 3% 769
4 CURRENT OPINION IN LIPIDOLOGY 27898 1% 11% 142
5 CURRENT ATHEROSCLEROSIS REPORTS 18660 0% 12% 82
6 ATHEROSCLEROSIS SUPPLEMENTS 18659 0% 19% 53
7 AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS 13672 0% 13% 56
8 CURRENT MEDICAL RESEARCH AND OPINION 13001 1% 4% 179
9 CLINICAL LIPIDOLOGY 10607 0% 12% 47
10 EUROPEAN HEART JOURNAL SUPPLEMENTS 9729 0% 7% 74

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class		 LCSH search Wikipedia search
1 STATINS 2447902 19% 43% 3116 Search STATINS Search STATINS
2 EZETIMIBE 670368 3% 68% 532 Search EZETIMIBE Search EZETIMIBE
3 SIMVASTATIN 605053 5% 40% 828 Search SIMVASTATIN Search SIMVASTATIN
4 HMG COA REDUCTASE INHIBITORS 549595 3% 54% 555 Search HMG+COA+REDUCTASE+INHIBITORS Search HMG+COA+REDUCTASE+INHIBITORS
5 ATORVASTATIN 513346 4% 39% 709 Search ATORVASTATIN Search ATORVASTATIN
6 PCSK9 355858 2% 76% 254 Search PCSK9 Search PCSK9
7 PRAVASTATIN 292862 2% 46% 347 Search PRAVASTATIN Search PRAVASTATIN
8 HYPERCHOLESTEROLEMIA 215972 4% 18% 657 Search HYPERCHOLESTEROLEMIA Search HYPERCHOLESTEROLEMIA
9 ROSUVASTATIN 215204 2% 41% 282 Search ROSUVASTATIN Search ROSUVASTATIN
10 NIACIN 199106 2% 39% 276 Search NIACIN Search NIACIN

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 ADAMS, SP , TSANG, M , WRIGHT, JM , (2012) LIPID LOWERING EFFICACY OF ATORVASTATIN.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 12. P. - 452 52% 1
2 SCHULZ, R , SCHLUTER, KD , LAUFS, U , (2015) MOLECULAR AND CELLULAR FUNCTION OF THE PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9).BASIC RESEARCH IN CARDIOLOGY. VOL. 110. ISSUE 2. P. - 167 95% 10
3 STONE, NJ , ROBINSON, JG , LICHTENSTEIN, AH , MERZ, CNB , BLUM, CB , ECKEL, RH , GOLDBERG, AC , GORDON, D , LEVY, D , LLOYD-JONES, DM , ET AL (2014) 2013 ACC/AHA GUIDELINE ON THE TREATMENT OF BLOOD CHOLESTEROL TO REDUCE ATHEROSCLEROTIC CARDIOVASCULAR RISK IN ADULTS A REPORT OF THE AMERICAN COLLEGE OF CARDIOLOGY/AMERICAN HEART ASSOCIATION TASK FORCE ON PRACTICE GUIDELINES.JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. VOL. 63. ISSUE 25. P. 2889 -2934 66 62% 762
4 GAZZERRO, P , PROTO, MC , GANGEMI, G , MALFITANO, AM , CIAGLIA, E , PISANTI, S , SANTORO, A , LAEZZA, C , BIFULCO, M , (2012) PHARMACOLOGICAL ACTIONS OF STATINS: A CRITICAL APPRAISAL IN THE MANAGEMENT OF CANCER.PHARMACOLOGICAL REVIEWS. VOL. 64. ISSUE 1. P. 102 -146 242 48% 106
5 BERGERON, N , PHAN, BAP , DING, YC , FONG, A , KRAUSS, RM , (2015) PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 INHIBITION A NEW THERAPEUTIC MECHANISM FOR REDUCING CARDIOVASCULAR DISEASE RISK.CIRCULATION. VOL. 132. ISSUE 17. P. 1648 -1666 119 89% 26
6 STONE, NJ , ROBINSON, JG , LICHTENSTEIN, AH , MERZ, CNB , BLUM, CB , ECKEL, RH , GOLDBERG, AC , GORDON, D , LEVY, D , LLOYD-JONES, DM , ET AL (2014) 2013 ACC/AHA GUIDELINE ON THE TREATMENT OF BLOOD CHOLESTEROL TO REDUCE ATHEROSCLEROTIC CARDIOVASCULAR RISK IN ADULTS A REPORT OF THE AMERICAN COLLEGE OF CARDIOLOGY/AMERICAN HEART ASSOCIATION TASK FORCE ON PRACTICE GUIDELINES.CIRCULATION. VOL. 129. ISSUE 25. P. S1 -S45 64 60% 708
7 GOLOMB, BA , EVANS, MA , (2008) STATIN ADVERSE EFFECTS A REVIEW OF THE LITERATURE AND EVIDENCE FOR A MITOCHONDRIAL MECHANISM.AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS. VOL. 8. ISSUE 6. P. 373 -418 262 45% 188
8 SEIDAH, NG , AWAN, Z , CHRETIEN, M , MBIKAY, M , (2014) PCSK9: A KEY MODULATOR OF CARDIOVASCULAR HEALTH.CIRCULATION RESEARCH. VOL. 114. ISSUE 6. P. 1022 -1036 105 80% 92
9 ALTWAIRGI, AK , (2015) STATINS ARE POTENTIAL ANTICANCEROUS AGENTS (REVIEW).ONCOLOGY REPORTS. VOL. 33. ISSUE 3. P. 1019 -1039 112 92% 16
10 AUER, J , SINZINGER, H , FRANKLIN, B , BERENT, R , (2016) MUSCLE- AND SKELETAL-RELATED SIDE-EFFECTS OF STATINS: TIP OF THE ICEBERG?.EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. VOL. 23. ISSUE 1. P. 88 -110 112 79% 6

Classes with closest relation at Level 2


Rank Class id link
1 3293 CHOLESTEROL//HYPOCHOLESTEROLEMIA//HLTH FAMILY STUDIES
2 1649 LIPOPROTEINA//FAMILIAL HYPERCHOLESTEROLEMIA//APOLIPOPROTEINA
3 3544 MONASCUS//CITRININ//MONASCUS PURPUREUS
4 43 JOURNAL OF LIPID RESEARCH//HDL//LIPOPROTEINS
5 406 HYPERTENSION//MEDICATION ADHERENCE//JOURNAL OF HUMAN HYPERTENSION
6 3244 COENZYME Q10//UBIQUINONE//COENZYME Q
7 3868 POLICOSANOL//TRIACONTANOL//OCTACOSANOL
8 3164 PHYSICIAN NUTRITION SPECIALIST//NUTRITION EDUCATION//MEDICAL NUTRITION EDUCATION
9 1952 CAROTID ARTERY//INTIMA MEDIA THICKNESS//ATHEROSCLEROSIS
10 1534 OXIDIZED LDL//ATHEROSCLEROSIS//LOX 1

Go to start page